Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…
← Haematology and transfusion indexChapter sections
Purpose and principlesIndications, selection and cautionsMethod and interpretationClinical next stepsRisks, monitoring and follow-upSpecial situationsCommon pitfallsQuestionsSources
Full textbook9 sectionsOpen only what you need
Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.

Interpreting the full blood count

Haematology and transfusion · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Time-critical presentation

New blasts, suspected acute promyelocytic leukaemia, severe neutropenia with fever or sepsis, thrombocytopenia with major bleeding, microangiopathic haemolysis, or symptomatic severe anaemia requires immediate clinical assessment and senior haematology contact. Repeat sampling can confirm an implausible result, but it must not delay treatment of an unwell patient.

Purpose and principles

Interpret every full-blood-count lineage in clinical context, recognise dangerous patterns and artefacts, and move from an abnormal number to a proportionate confirmatory and referral plan.

A full blood count measures several related but biologically distinct systems. Haemoglobin and red-cell indices describe oxygen-carrying cells; the white-cell differential reflects innate, adaptive and clonal populations; platelets reflect production, consumption, destruction and sequestration. Interpretation begins by deciding whether one, two or three lineages are abnormal and whether the change is acute, chronic, progressive or intermittent. Recent fluids, bleeding, transfusion, pregnancy, infection, surgery and medicines can alter several values simultaneously, so the request time and clinical state belong beside the numerical report.

Red-cell reasoning should separate size from marrow response. Microcytosis directs attention towards iron restriction and haemoglobinopathy, whereas macrocytosis can reflect B12 or folate deficiency, alcohol, liver disease, hypothyroidism, reticulocytosis, medicines or marrow dysplasia. Normocytic anaemia is not diagnostically neutral: early deficiency, renal disease, inflammation, haemolysis and acute blood loss remain possible. Reticulocytes show whether marrow output is appropriate for the degree of anaemia, but recent transfusion and deficient iron, B12 or folate can blur the expected response.

Key points

  • Read haemoglobin, white-cell differential and platelets together before focusing on a flagged value; abnormalities across several lineages suggest marrow, infiltrative, consumptive or systemic disease rather than an isolated deficiency.
  • Compare with the patient's baseline and the laboratory's age-, sex- and pregnancy-appropriate reference interval. Direction and speed of change often carry more clinical information than a single result just outside range.
  • For anaemia, begin with mean cell volume, mean cell haemoglobin, red-cell distribution width and reticulocytes, then integrate film, iron studies, B12, folate, renal, inflammatory and haemolysis testing as the phenotype directs.
  • Use absolute neutrophil, lymphocyte, eosinophil, basophil and monocyte counts rather than percentages. A normal total white count can conceal a clinically important differential-count abnormality.
  • Confirm unexpected thrombocytopenia on a fresh citrate or otherwise laboratory-advised sample and film when platelet clumping is possible, while examining for bleeding, sepsis, drugs and thrombotic microangiopathy.
  • A machine flag is a request for review, not a diagnosis. Blasts, nucleated red cells, schistocytes, atypical lymphocytes and platelet clumps need skilled film correlation and clinical context.
  • Do not

Indications, selection and cautions

Isolated anaemia

Low haemoglobin with preserved white cells and platelets supports an erythroid, nutritional, renal, inflammatory, bleeding or haemolytic process. Symptoms and haemodynamic state determine urgency before morphology defines cause.

Multilineage cytopeniaRed flag

Anaemia plus neutropenia and thrombocytopenia raises marrow failure, infiltration, acute leukaemia, severe deficiency, sepsis, hypersplenism or treatment toxicity. Fever, bleeding or blasts makes the pattern urgent.

Proliferative count pattern

Persistent leucocytosis, basophilia, thrombocytosis, circulating immature myeloid cells or splenomegaly suggests a myeloproliferative or leukaemic process after reactive causes are assessed.

Possible sample artefact

Platelet clumps, an implausible abrupt haemoglobin change, cold-agglutinin analyser flags or a result incompatible with the patient should prompt laboratory discussion and a correctly handled repeat sample.

Critical acute patternRed flag

Blasts, promyelocytes with coagulopathy, schistocytes with thrombocytopenia, profound neutropenia with fever, or active bleeding with severe thrombocytopenia requires same-hour clinical and haematology escalation.

Method and interpretation

  1. 01
    Repeat FBC with differential and prior-result reviewFirst step
    Why
    Confirm an unexpected abnormality and establish its trajectory across all lineages.
    Interpretation and limitations
    Use a fresh sample when pre-analytical error is plausible, but first assess an unwell patient. Stable chronicity narrows the differential; a rapid fall or rise suggests bleeding, haemolysis, consumption, acute inflammation, drug effect or evolving marrow disease.
  2. 02
    Peripheral blood film
    Why
    Verify analyser flags and identify morphology that changes urgency or directs testing.
    Interpretation and limitations
    Blasts or abnormal promyelocytes trigger urgent acute-leukaemia pathways; schistocytes suggest mechanical fragmentation or thrombotic microangiopathy; spherocytes, target cells, teardrops, rouleaux and toxic change require cause-specific correlation rather than diagnosis from one cell.
  3. 03
    Reticulocyte count and haemolysis profile
    Why
    Determine whether marrow production is appropriate and whether red-cell destruction is occurring.
    Interpretation and limitations
    An appropriately raised absolute reticulocyte count supports blood loss or haemolysis, while a low response suggests impaired production. Interpret bilirubin, LDH, haptoglobin and direct antiglobulin test together and account for recent transfusion or deficiency.
  4. 04
    Ferritin, transferrin saturation, B12 and folate
    Why

Clinical next steps

01ImmediateRespond to a dangerous count patternFirst stepThe patient is unwell, bleeding or febrile, or the report shows blasts, severe cytopenia, fragmentation or a critical laboratory alert.+
  1. 1Assess ABCDE, confirm symptoms and observations, inspect for bleeding or infection, obtain urgent repeat and film samples where this causes no harmful delay, and contact senior haematology.
  2. 2PreferredUse the supported emergency pathway: preferred management is immediate neutropenic-sepsis treatment for fever with significant neutropenia, a TTP pathway for microangiopathic haemolysis, or an acute-leukaemia pathway for blasts or abnormal promyelocytes.
  3. 3EscalationEscalate active major bleeding, haemodynamic compromise, neurological change or suspected disseminated coagulopathy to critical care and transfusion support; do not wait for a complete outpatient investigation panel.

Risks, monitoring and follow-up

  • Trend each lineage against dates, clinical events, transfusions and treatment rather than copying isolated flags into the problem list.
  • For anaemia, monitor symptoms, haemoglobin, reticulocyte response and the cause-specific marker; failure to respond should trigger adherence, absorption, bleeding, inflammation and diagnostic review.
  • For neutropenia, provide explicit fever and infection safety-netting and increase monitoring after chemotherapy, marrow-toxic medicines or a falling serial count.
  • For thrombocytopenia, document bleeding, platelet trajectory, anticoagulant or antiplatelet exposure and any planned procedure instead of using the count alone.
  • Assign a named clinician to pending film comments, flow cytometry, molecular tests and referrals, and communicate a critical revised result directly.

Special situations

Reference ranges are statistical

A result just outside range can occur in health, whereas a technically normal result may be abnormal for that patient's baseline. Magnitude, trajectory and phenotype determine meaning.

Percentages conceal absolute counts

A high lymphocyte percentage during neutropenia may coexist with a normal absolute lymphocyte count. Clinical decisions use the relevant absolute population.

Normal MCV can hide two processes

Iron deficiency with B12 deficiency, or microcytosis with reticulocytosis, may average to a normocytic index. RDW and film can expose the mixed population.

Platelets are vulnerable to artefact

EDTA-dependent clumping can produce a false low count and an unnecessary bleeding pathway. Film review and a laboratory-advised alternative tube clarify the result.

A normal count is not reassurance alone

Early marrow or lymphoid malignancy can present with symptoms and normal circulating counts. Examination and symptom-led imaging or tissue remain important.

Common pitfalls

  1. 01

    Interpreting the total white count without reading the absolute differential.

  2. 02

    Calling every normocytic anaemia anaemia of chronic disease without reticulocytes, renal assessment, haematinics and bleeding review.

  3. 03

    Treating an analyser flag as a diagnosis without a film or laboratory discussion.

  4. 04

    Repeating a critical result several hours later without assessing the patient now.

  5. 05

    Accepting platelet clumping as true thrombocytopenia and stopping essential treatment unnecessarily.

  6. 06

    Failing to act on a later film comment because no clinician owns the result.

Practice

Two practice questions

Your practice draft is saved in this browser.

Question 1 of 2
0 correct
Haematology and transfusionOriginal SBA

Three-line count abnormality

A previously well adult has fatigue, bruising, haemoglobin 82 g/L, neutrophils 0.7 × 10⁹/L and platelets 34 × 10⁹/L. The analyser flags possible blasts. What is the best immediate approach?

Choose one answer, then submit
← Rapid synopsisBack to overviewAll Haematology and transfusion topics →
Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG12 suspected cancer recommendationsReferral context for unexplained cytopenias, leucocytosis, lymphadenopathy and splenomegaly.
  • NICE CG151 neutropenic sepsis recommendationsImmediate assessment and treatment when neutropenia accompanies fever or sepsis.
  • Royal College of Pathologists retesting guidanceSafe repeat-testing intervals and avoidance of unhelpful duplication.
  • BNF anaemias treatment summaryUK context for haematinic treatment after the count phenotype has been established.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateComplete draftClinical stateAwaiting reviewJurisdictionUnited Kingdom
White-cell and platelet abnormalities require the same discipline. Neutrophilia may be reactive to infection, inflammation, corticosteroids or stress, but left shift, basophilia, splenomegaly or persistence can suggest a myeloid neoplasm. Lymphocytosis may be reactive or clonal; morphology, duration, age and symptoms determine the next test. Thrombocytopenia may be artefactual, immune, consumptive, drug-related, infective, hepatic or marrow based. Thrombocytosis is often reactive to inflammation or iron deficiency, yet persistent unexplained elevation warrants a clonal assessment. The safe output is a problem representation and next action, not a list of every possible cause.
use the full blood count as a cancer rule-out test. Persistent lymphadenopathy, splenomegaly, weight loss, unexplained bleeding or recurrent infection can require investigation despite initially normal counts.
  • Close the loop on critical laboratory calls: verify identity and sampling, assess the patient, compare prior results, repeat only when useful, and record who will act on film, culture, haematinic or referral results.
    • Identify common substrate deficiencies behind anaemia or macrocytosis.
    Interpretation and limitations
    Low ferritin supports depleted iron stores, but inflammation can raise ferritin and conceal iron restriction. B12 results need NICE's indeterminate and functional-testing pathway; folate should not be replaced in isolation before B12 has been considered.
  • 05
    Renal, liver, thyroid and inflammatory profile
    Why
    Find systemic causes and contextualise reactive count changes.
    Interpretation and limitations
    Renal impairment, liver disease, hypothyroidism and inflammation can each alter indices. Their presence does not automatically explain a severe or progressive abnormality, and mixed aetiologies are common.
  • 06
    Flow cytometry, molecular testing or bone marrow assessment
    Why
    Characterise a persistent clonal or marrow-failure phenotype after initial review.
    Interpretation and limitations
    Select the test with haematology and the laboratory: flow may classify a lymphoid clone, molecular tests can support a myeloid neoplasm, and marrow morphology supplies architecture, lineage and fibrosis information.
    • 02One lineageCharacterise an isolated abnormalityOne lineage is abnormal and the patient has no immediate physiological or bleeding emergency.+
    1. 1Check baseline, duration, medicines, alcohol, infection, inflammation, bleeding and examination, then confirm indices and the absolute differential rather than relying on the headline flag.
    2. 2First lineFirst-line tests are phenotype directed: reticulocytes, film and haematinics for anaemia; film and infection or medication review for white-cell change; film and a clumping check for thrombocytopenia.
    3. 3PreferredAlternativeIf the result persists without a reactive explanation, the preferred next step is haematology- or laboratory-guided flow, molecular or marrow testing; an alternative is interval reassessment only when clinical risk and trajectory are low.
    03Several lineagesInvestigate marrow and systemic causesTwo or three cell lines are reduced or a cytopenia accompanies abnormal circulating cells.+
    1. 1Repeat with film and reticulocytes, review all medicines and toxins, and obtain haematinics, haemolysis, liver, renal, viral and inflammatory tests selected for the history.
    2. 2PreferredLook for splenomegaly, lymphadenopathy, infection, autoimmune disease and constitutional symptoms; urgent referral is preferred when counts are worsening, blasts are present or marrow failure is clinically likely.
    3. 3EscalationEscalate to bone-marrow aspiration and trephine when peripheral testing does not resolve a significant persistent pattern or when acute leukaemia, aplasia, infiltration or myelodysplasia is suspected.